NCT02839278View on ClinicalTrials.gov

Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 2, 2024

Study Completion Date

September 2, 2024

Conditions
Inflammation
Interventions
BIOLOGICAL

Blood sample

Trial Locations (1)

Unknown

University Hospital, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02839278 - Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases | Biotech Hunter | Biotech Hunter